Cargando…
Ellagic Acid: A Dietary-Derived Phenolic Compound for Drug Discovery in Mild Cognitive Impairment
Ellagic acid (EA), a naturally occurring polyphenolic compound, is detected in free form or linked to polyols or sugars, constituting hydrolyzable tannins or ellagitannins in distinct fruits, nuts, and herbs. Today, a considerable number of botanicals and enriched foods containing EA are commerciall...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289475/ https://www.ncbi.nlm.nih.gov/pubmed/35860668 http://dx.doi.org/10.3389/fnagi.2022.925855 |
_version_ | 1784748674614558720 |
---|---|
author | Wang, Wenjun Wang, Shaohui Liu, Yue Wang, Xiaobo Nie, Jia Meng, Xianli Zhang, Yi |
author_facet | Wang, Wenjun Wang, Shaohui Liu, Yue Wang, Xiaobo Nie, Jia Meng, Xianli Zhang, Yi |
author_sort | Wang, Wenjun |
collection | PubMed |
description | Ellagic acid (EA), a naturally occurring polyphenolic compound, is detected in free form or linked to polyols or sugars, constituting hydrolyzable tannins or ellagitannins in distinct fruits, nuts, and herbs. Today, a considerable number of botanicals and enriched foods containing EA are commercially available as nutraceuticals and used to prevent mild cognitive impairment (MCI) due to the excellent neuroprotective capacity of EA. Here, this study aims to provide an overview of the physicochemical properties, source, and pharmacokinetics of EA and to emphasize the importance and mechanisms of EA in the prevention and management of MCI. To date, preclinical studies of EA and its derivatives in various cell lines and animal models have advanced the idea of dietary EA as a feasible agent capable of specifically targeting and improving MCI. The molecular mechanisms of EA and its derivatives to prevent or reduce MCI are mainly through reducing neuroinflammation, oxidative stress, neuronal apoptosis, synaptic dysfunction and loss, and defective mitochondrial functions. Nevertheless, well-designed and correctly large randomized controlled trials in the human population need to be performed to reinforce the scientific facticity of the beneficial effects of EA against MCI. Synchronously, the mechanism of EA against MCI is least provided cynosure and expects more attention from the emerging research community. |
format | Online Article Text |
id | pubmed-9289475 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92894752022-07-19 Ellagic Acid: A Dietary-Derived Phenolic Compound for Drug Discovery in Mild Cognitive Impairment Wang, Wenjun Wang, Shaohui Liu, Yue Wang, Xiaobo Nie, Jia Meng, Xianli Zhang, Yi Front Aging Neurosci Aging Neuroscience Ellagic acid (EA), a naturally occurring polyphenolic compound, is detected in free form or linked to polyols or sugars, constituting hydrolyzable tannins or ellagitannins in distinct fruits, nuts, and herbs. Today, a considerable number of botanicals and enriched foods containing EA are commercially available as nutraceuticals and used to prevent mild cognitive impairment (MCI) due to the excellent neuroprotective capacity of EA. Here, this study aims to provide an overview of the physicochemical properties, source, and pharmacokinetics of EA and to emphasize the importance and mechanisms of EA in the prevention and management of MCI. To date, preclinical studies of EA and its derivatives in various cell lines and animal models have advanced the idea of dietary EA as a feasible agent capable of specifically targeting and improving MCI. The molecular mechanisms of EA and its derivatives to prevent or reduce MCI are mainly through reducing neuroinflammation, oxidative stress, neuronal apoptosis, synaptic dysfunction and loss, and defective mitochondrial functions. Nevertheless, well-designed and correctly large randomized controlled trials in the human population need to be performed to reinforce the scientific facticity of the beneficial effects of EA against MCI. Synchronously, the mechanism of EA against MCI is least provided cynosure and expects more attention from the emerging research community. Frontiers Media S.A. 2022-07-04 /pmc/articles/PMC9289475/ /pubmed/35860668 http://dx.doi.org/10.3389/fnagi.2022.925855 Text en Copyright © 2022 Wang, Wang, Liu, Wang, Nie, Meng and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Aging Neuroscience Wang, Wenjun Wang, Shaohui Liu, Yue Wang, Xiaobo Nie, Jia Meng, Xianli Zhang, Yi Ellagic Acid: A Dietary-Derived Phenolic Compound for Drug Discovery in Mild Cognitive Impairment |
title | Ellagic Acid: A Dietary-Derived Phenolic Compound for Drug Discovery in Mild Cognitive Impairment |
title_full | Ellagic Acid: A Dietary-Derived Phenolic Compound for Drug Discovery in Mild Cognitive Impairment |
title_fullStr | Ellagic Acid: A Dietary-Derived Phenolic Compound for Drug Discovery in Mild Cognitive Impairment |
title_full_unstemmed | Ellagic Acid: A Dietary-Derived Phenolic Compound for Drug Discovery in Mild Cognitive Impairment |
title_short | Ellagic Acid: A Dietary-Derived Phenolic Compound for Drug Discovery in Mild Cognitive Impairment |
title_sort | ellagic acid: a dietary-derived phenolic compound for drug discovery in mild cognitive impairment |
topic | Aging Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289475/ https://www.ncbi.nlm.nih.gov/pubmed/35860668 http://dx.doi.org/10.3389/fnagi.2022.925855 |
work_keys_str_mv | AT wangwenjun ellagicacidadietaryderivedphenoliccompoundfordrugdiscoveryinmildcognitiveimpairment AT wangshaohui ellagicacidadietaryderivedphenoliccompoundfordrugdiscoveryinmildcognitiveimpairment AT liuyue ellagicacidadietaryderivedphenoliccompoundfordrugdiscoveryinmildcognitiveimpairment AT wangxiaobo ellagicacidadietaryderivedphenoliccompoundfordrugdiscoveryinmildcognitiveimpairment AT niejia ellagicacidadietaryderivedphenoliccompoundfordrugdiscoveryinmildcognitiveimpairment AT mengxianli ellagicacidadietaryderivedphenoliccompoundfordrugdiscoveryinmildcognitiveimpairment AT zhangyi ellagicacidadietaryderivedphenoliccompoundfordrugdiscoveryinmildcognitiveimpairment |